|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 6 (September 15), 1998:
pp. 1859-1869
RAPID COMMUNICATION
Activation of p38 MAP Kinase and JNK But Not ERK Is Required for
Erythropoietin-Induced Erythroid Differentiation
Yuka Nagata,
Noriko Takahashi,
Roger J. Davis, and
Kazuo Todokoro
From the Tsukuba Life Science Center, The Institute of Physical and
Chemical Research (RIKEN), Ibaraki, Japan; and the Howard Hughes
Medical Institute, Program in Molecular Medicine, Department of
Biochemistry and Molecular Biology, University of Massachusetts Medical
School, Worcester, MA.
p38 MAP kinase (p38) and JNK have been described as playing a
critical role in the response to a variety of environmental stresses
and proinflammatory cytokines. It was recently reported that
hematopoietic cytokines activate not only classical MAP kinases (ERK),
but also p38 and JNK. However, the physiological function of these
kinases in hematopoiesis remains obscure. We found that all MAP kinases
examined, ERK1, ERK2, p38, JNK1, and JNK2, were rapidly and transiently
activated by erythropoietin (Epo) stimulation in SKT6 cells, which can
be induced to differentiate into hemoglobinized cells in response to
Epo. Furthermore, p38-specific inhibitor SB203580 but not MEK-specific
inhibitor PD98059 significantly suppressed Epo-induced differentiation
and antisense oligonucleotides of p38, JNK1, and JNK2, but neither ERK1
nor ERK2 clearly inhibited Epo-induced hemoglobinization. However, in
Epo-dependent FD-EPO cells, inhibition of either ERKs, p38, or JNKs
suppressed cell growth. Furthermore, forced expression of a
gain-of-function MKK6 mutant, which specifically activated p38, induced
hemoglobinization of SKT6 cells without Epo. These results indicate
that activation of p38 and JNKs but not of ERKs is required for
Epo-induced erythroid differentiation of SKT6 cells, whereas all of
these kinases are involved in Epo-induced mitogenesis of FD-EPO cells.
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. K. Zaidi, C. R. Dowdy, A. J. van Wijnen, J. B. Lian, A. Raza, J. L. Stein, C. M. Croce, and G. S. Stein
Altered Runx1 Subnuclear Targeting Enhances Myeloid Cell Proliferation and Blocks Differentiation by Activating a miR-24/MKP-7/MAPK Network
Cancer Res.,
November 1, 2009;
69(21):
8249 - 8255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Geest and P. J. Coffer
MAPK signaling pathways in the regulation of hematopoiesis
J. Leukoc. Biol.,
August 1, 2009;
86(2):
237 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tanaka, T. Owaki, S. Kamiya, T. Matsunaga, K. Shimoda, H. Kodama, R. Hayashi, T. Abe, Y. P. Harada, M. Shimonaka, et al.
VLA-5-mediated Adhesion to Fibronectin Accelerates Hemin-stimulated Erythroid Differentiation of K562 Cells through Induction of VLA-4 Expression
J. Biol. Chem.,
July 24, 2009;
284(30):
19817 - 19825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Dalmas, L. A. Tierney, C. Zhang, P. K. Narayanan, R. W. Boyce, L. W. Schwartz, K. S. Frazier, and M. S. Scicchitano
Effects of p38 MAP Kinase Inhibitors on the Differentiation and Maturation of Erythroid Progenitors
Toxicol Pathol,
December 1, 2008;
36(7):
958 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bose and K. B. Udupa
Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals
Am J Physiol Cell Physiol,
August 1, 2008;
295(2):
C394 - C405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ahuja, P. Sdek, and W. R. MacLellan
Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
Physiol Rev,
April 1, 2007;
87(2):
521 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bugarski, A. Krstic, S. Mojsilovic, M. Vlaski, M. Petakov, G. Jovcic, N. Stojanovic, and P. Milenkovic
Signaling Pathways Implicated in Hematopoietic Progenitor Cell Proliferation and Differentiation
Experimental Biology and Medicine,
January 1, 2007;
232(1):
156 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sangerman, M. S. Lee, X. Yao, E. Oteng, C.-H. Hsiao, W. Li, S. Zein, S. F. Ofori-Acquah, and B. S. Pace
Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves {gamma}-globin activation by CREB1 and ATF-2
Blood,
November 15, 2006;
108(10):
3590 - 3599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Menon, J. Fang, and D. M. Wojchowski
Core erythropoietin receptor signals for late erythroblast development
Blood,
April 1, 2006;
107(7):
2662 - 2672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Brown and S. Benchimol
The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation: CELL CYCLE ARREST OR APOPTOSIS
J. Biol. Chem.,
February 17, 2006;
281(7):
3832 - 3840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nishigaki, C. Hanson, D. Thompson, T. Yugawa, and S. Ruscetti
Activation of the Jun N-Terminal Kinase Pathway by Friend Spleen Focus-Forming Virus and Its Role in the Growth and Survival of Friend Virus-Induced Erythroleukemia Cells
J. Virol.,
October 15, 2005;
79(20):
12752 - 12762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Renukaradhya, T. J. R. Webb, M. A. Khan, Y. L. Lin, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz
Virus-Induced Inhibition of CD1d1-Mediated Antigen Presentation: Reciprocal Regulation by p38 and ERK
J. Immunol.,
October 1, 2005;
175(7):
4301 - 4308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. P. Kim, X. Wang, A. Nakao, S. I. Kim, N. Murase, M. E. Choi, S. W. Ryter, and A. M. K. Choi
Caveolin-1 expression by means of p38{beta} mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide
PNAS,
August 9, 2005;
102(32):
11319 - 11324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Daoud, M. Amyot, E. Rassart, A. Masse, L. Simoneau, and J. Lafond
ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta
J. Physiol.,
July 15, 2005;
566(2):
409 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Kumar, G. Acs, D. Fang, M. Herlyn, D. E. Elder, and X. Xu
Functional Erythropoietin Autocrine Loop in Melanoma
Am. J. Pathol.,
March 1, 2005;
166(3):
823 - 830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Jacobs-Helber and S. T. Sawyer
Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines
Blood,
August 1, 2004;
104(3):
696 - 703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-S. Zhu, L. J. Robinson, V. Roginskaya, and S. J. Corey
G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses
Blood,
May 1, 2004;
103(9):
3305 - 3312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Baeza-Raja and P. Munoz-Canoves
p38 MAPK-induced Nuclear Factor-{kappa}B Activity Is Required for Skeletal Muscle Differentiation: Role of Interleukin-6
Mol. Biol. Cell,
April 1, 2004;
15(4):
2013 - 2026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Secchiero, E. Melloni, M. Heikinheimo, S. Mannisto, R. Di Pietro, A. Iacone, and G. Zauli
TRAIL regulates normal erythroid maturation through an ERK-dependent pathway
Blood,
January 15, 2004;
103(2):
517 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Uddin, J. Ah-Kang, J. Ulaszek, D. Mahmud, and A. Wickrema
Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells
PNAS,
January 6, 2004;
101(1):
147 - 152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Platanias
Map kinase signaling pathways and hematologic malignancies
Blood,
June 15, 2003;
101(12):
4667 - 4679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guillard, S. Chretien, A.-S. Pelus, F. Porteu, O. Muller, P. Mayeux, and V. Duprez
Activation of the Mitogen-activated Protein Kinases Erk1/2 by Erythropoietin Receptor via a Gi Protein beta gamma -Subunit-initiated Pathway
J. Biol. Chem.,
March 21, 2003;
278(13):
11050 - 11056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Witt, S. Monkemeyer, G. Ronndahl, B. Erdlenbruch, D. Reinhardt, K. Kanbach, and A. Pekrun
Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin
Blood,
March 1, 2003;
101(5):
2001 - 2007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Jacobs-Helber, K.-h. Roh, D. Bailey, E. N. Dessypris, J. J. Ryan, J. Chen, A. Wickrema, D. L. Barber, P. Dent, and S. T. Sawyer
Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia
Blood,
January 15, 2003;
101(2):
524 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M.-Y. Ho, M. H.-H. Nguyen, J. K. Dierov, K. M. Badger, B. K. Beattie, P. Tartaro, R. Haq, B. W. Zanke, M. P. Carroll, and D. L. Barber
TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways
Blood,
July 30, 2002;
100(4):
1438 - 1448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Haq, A. Halupa, B. K. Beattie, J. M. Mason, B. W. Zanke, and D. L. Barber
Regulation of Erythropoietin-induced STAT Serine Phosphorylation by Distinct Mitogen-activated Protein Kinases
J. Biol. Chem.,
May 3, 2002;
277(19):
17359 - 17366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Jacobs-Helber, R. M. Abutin, C. Tian, M. Bondurant, A. Wickrema, and S. T. Sawyer
Role of JunB in Erythroid Differentiation
J. Biol. Chem.,
February 8, 2002;
277(7):
4859 - 4866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Barnache, P. Mayeux, B. Payrastre, and F. Moreau-Gachelin
Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts
Blood,
October 15, 2001;
98(8):
2372 - 2381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-I. Park, H.-S. Choi, J.-S. Jeong, J.-Y. Han, and I.-H. Kim
Involvement of p38 Kinase in Hydroxyurea-induced Differentiation of K562 Cells
Cell Growth Differ.,
September 1, 2001;
12(9):
481 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rabehi, T. Irinopoulou, B. Cholley, N. Haeffner-Cavaillon, and M.-P. Carreno
Gram-Positive and Gram-Negative Bacteria Do Not Trigger Monocytic Cytokine Production through Similar Intracellular Pathways
Infect. Immun.,
July 1, 2001;
69(7):
4590 - 4599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Kadri, E. Petitfrère, C. Boudot, J.-M. Freyssinier, S. Fichelson, P. Mayeux, H. Emonard, W. Hornebeck, B. Haye, and C. Billat
Erythropoietin Induction of Tissue Inhibitors of Metalloproteinase-1 Expression and Secretion Is Mediated by Mitogen-activated Protein Kinase and Phosphatidylinositol 3-kinase Pathways
Cell Growth Differ.,
November 1, 2000;
11(11):
573 - 580.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Adachi, B. K. Choudhury, S. Stafford, S. Sur, and R. Alam
The Differential Role of Extracellular Signal-Regulated Kinases and p38 Mitogen-Activated Protein Kinase in Eosinophil Functions
J. Immunol.,
August 15, 2000;
165(4):
2198 - 2204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Jacobs-Helber, J. J. Ryan, and S. T. Sawyer
JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells
Blood,
August 1, 2000;
96(3):
933 - 940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Witt, K. Sand, and A. Pekrun
Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways
Blood,
April 1, 2000;
95(7):
2391 - 2396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. McCormack and T. J. Gonda
Novel murine myeloid cell lines that exhibit a differentiation switch in response to IL-3 or GM-CSF, or to different constitutively active mutants of the GM-CSF receptor beta subunit
Blood,
January 1, 2000;
95(1):
120 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Shan, J. O. Price, W. A. Gaarde, B. P. Monia, S. B. Krantz, and Z. J. Zhao
Distinct Roles of JNKs/p38 MAP Kinase and ERKs in Apoptosis and Survival of HCD-57 Cells Induced by Withdrawal or Addition of Erythropoietin
Blood,
December 15, 1999;
94(12):
4067 - 4076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chen, B. H. Davis, M. Bissonnette, B. Scaglione-Sewell, and T. A. Brasitus
1,25-Dihydroxyvitamin D3 Stimulates Activator Protein-1-dependent Caco-2 Cell Differentiation
J. Biol. Chem.,
December 10, 1999;
274(50):
35505 - 35513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Engelman, A. H. Berg, R. Y. Lewis, A. Lin, M. P. Lisanti, and P. E. Scherer
Constitutively Active Mitogen-activated Protein Kinase Kinase 6 (MKK6) or Salicylate Induces Spontaneous 3T3-L1 Adipogenesis
J. Biol. Chem.,
December 10, 1999;
274(50):
35630 - 35638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Galbiati, D. Volonte, J. A. Engelman, P. E. Scherer, and M. P. Lisanti
Targeted Down-regulation of Caveolin-3 Is Sufficient to Inhibit Myotube Formation in Differentiating C2C12 Myoblasts. TRANSIENT ACTIVATION OF p38 MITOGEN-ACTIVATED PROTEIN KINASE IS REQUIRED FOR INDUCTION OF CAVEOLIN-3 EXPRESSION AND SUBSEQUENT MYOTUBE FORMATION
J. Biol. Chem.,
October 15, 1999;
274(42):
30315 - 30321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fichelson, J.-M. Freyssinier, F. Picard, M. Fontenay-Roupie, M. Guesnu, M. Cherai, S. Gisselbrecht, and F. Porteu
Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in Primitive Cord Blood Hematopoietic Progenitors
Blood,
September 1, 1999;
94(5):
1601 - 1613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nagata and K. Todokoro
Requirement of Activation of JNK and p38 for Environmental Stress-Induced Erythroid Differentiation and Apoptosis and of Inhibition of ERK for Apoptosis
Blood,
August 1, 1999;
94(3):
853 - 863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Car and R. T. Robertson
Commentary: Discovery Toxicology--A Nascent Science
Toxicol Pathol,
July 1, 1999;
27(4):
481 - 483.
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nagata, F. Kiefer, T. Watanabe, and K. Todokoro
Activation of Hematopoietic Progenitor Kinase-1 by Erythropoietin
Blood,
May 15, 1999;
93(10):
3347 - 3354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Nath, H. Bian, E. F. Reed, and S. P. Chellappan
HLA Class I-Mediated Induction of Cell Proliferation Involves Cyclin E-Mediated Inactivation of Rb Function and Induction of E2F Activity
J. Immunol.,
May 1, 1999;
162(9):
5351 - 5358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Lam, C. Ronchini, J. Norton, A. J. Capobianco, and E. H. Bresnick
Suppression of Erythroid but Not Megakaryocytic Differentiation of Human K562 Erythroleukemic Cells by Notch-1
J. Biol. Chem.,
June 23, 2000;
275(26):
19676 - 19684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Alsayed, S. Uddin, N. Mahmud, F. Lekmine, D. V. Kalvakolanu, S. Minucci, G. Bokoch, and L. C. Platanias
Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to All-trans-retinoic Acid
J. Biol. Chem.,
February 2, 2001;
276(6):
4012 - 4019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Das, D. M. Bouchey, M. J. Moore, D. C. Hopkins, R. A. Nemenoff, and K. R. Stenmark
Hypoxia-induced Proliferative Response of Vascular Adventitial Fibroblasts Is Dependent on G Protein-mediated Activation of Mitogen-activated Protein Kinases
J. Biol. Chem.,
May 4, 2001;
276(19):
15631 - 15640.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|